UBS raises Unum Group stock price target to $94 on LTC deal

UBS raised its Unum Group (UNM) price target to $94 from $85 (Neutral) as the stock at $89.38 trades below UBS’s target and InvestingPro’s $96.41 fair value, implying it is still undervalued. The update follows a second external long-term care (LTC) deal that offloads 26% of Unum’s LTC block (and 52% of the individual LTC component), costs about $650M of holding company capital, and is expected to limit operating earnings impact mainly to interest expense and lost net investment income. UBS also reiterated Unum can execute its $1B-plus 2026 buyback plan while continuing shareholder-friendly capital returns (2.06% dividend yield; 17 straight years of dividend increases).

Analysis

The important change is not the accounting headline; it is the removal of a long-duration tail that has been suppressing valuation. Once a legacy block becomes less of a black box, UNM’s equity story shifts from reserve anxiety to capital deployment, which typically compresses the discount rate applied by the market over the next 1-3 months. That creates a cleaner path for buybacks to matter, because repurchases on a de-risked balance sheet are more likely to be treated as permanent per-share value creation rather than financial engineering.

The second-order winner is likely the wider life/health insurance complex: investors tend to reward companies that can demonstrate runoff execution, and that can lift sentiment toward names with credible excess capital and legacy cleanup optionality such as PRU, MET, and CNO. The bigger beneficiary over 6-18 months may be the reinsurance/risk-transfer ecosystem, where capacity providers and runoff managers can monetize demand for balance-sheet repair; that supports firms like RGA and Fortitude-linked structures more than it does core operating insurers.

The contrarian risk is that the market overstates the immediate earnings benefit. Near term, the drag from foregone net investment income plus higher funding/hedging costs can offset the capital release, and a temporarily weaker RBC ratio could slow the promised repurchase pace. What would falsify the bullish thesis is any sign that reserve experience worsens, capital return slips below management’s implied cadence, or the deal fails to translate into a higher multiple within the next two earnings cycles.

Key Decisions for Investors

• Long UNM common on any post-event pullback; target a 6-10% re-rating over 1-3 months as legacy-risk discount narrows, with a stop if management signals buybacks are delayed or capital ratios tighten.
• For a cleaner relative-value expression, pair long UNM / short PRU for 3-6 months: UNM has more visible de-risking momentum, while PRU still carries more legacy complexity and should lag if the market rewards balance-sheet simplification.
• Buy UNM Jan-2026 90/105 call spreads if implied vol remains subdued; the structure captures buyback-driven EPS accretion and multiple expansion with defined downside, while limiting exposure if reserve news turns adverse.
• Watch RGA and runoff-capacity names for sympathy upside over the next 1-3 months; if more insurers follow UNM’s playbook, capital-recycling specialists should see incremental deal flow and fee opportunities.